Premium
Reducing the risk of post‐endoscopic retrograde cholangiopancreatography pancreatitis
Author(s) -
Elmunzer B. Joseph
Publication year - 2017
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/den.12908
Subject(s) - medicine , endoscopic retrograde cholangiopancreatography , pancreatitis , incidence (geometry) , intensive care medicine , complication , general surgery , risk stratification , surgery , physics , optics
Pancreatitis is the most common and potentially devastating complication of endoscopic retrograde cholangiopancreatography ( ERCP ), resulting in significant morbidity, occasional mortality, and increased health‐care expenditure. Accordingly, the prevention of post‐ ERCP pancreatitis ( PEP ) remains a major clinical and research priority. Strategies to reduce the incidence of PEP include thoughtful patient selection, appropriate risk‐stratification, sound procedural technique, prophylactic pancreatic stent placement, and pharmacoprevention. Despite advances in all these areas, however, the incidence of PEP remains as high as 15% in high‐risk cases. Thus, additional research towards the goal of eliminating PEP is necessary. Herein is an evidence‐based review of strategies to prevent pancreatitis after ERCP , focusing on recent important developments in the field.